Eli Lilly's New Weight Loss Pill Is Here (And It's Cheap)
Foundayo just got FDA approval and starts at $149 cash - way less than we expected. But how does it stack up against the competition?
The pill we've been waiting for is finally here
Eli Lilly just got FDA approval for Foundayo (orforglipron) - their first daily pill for weight loss. After years of injections dominating the GLP-1 space, having another oral option feels like a big deal, especially for anyone who's needle-phobic.
Here's what caught my attention: the pricing is actually reasonable. We're talking $149 per month if you're paying cash, which drops to around $25 with most insurance plans. Compare that to Wegovy or other brand-name options, and Foundayo looks pretty appealing from a wallet perspective.
The results are solid, but not spectacular
In clinical trials, people lost between 7.8% and 12.4% of their body weight over 72 weeks. That translates to about 25 pounds for the average person, with some seeing up to 27 pounds on the highest dose.
Those numbers are decent - not mind-blowing, but definitely in the range where you'd notice a real difference. What's interesting is how this compares to Novo Nordisk's oral Wegovy, which showed 13.6% weight loss in their studies. So Foundayo's running a bit behind, but not by much.
Getting your hands on it won't be hard
Lilly's moving fast on availability. The medication hits pharmacies on April 6th, and they're even partnering with TrumpRx (that government price comparison site) to make ordering easier.
For Medicare folks, you're looking at around $50 per month starting July 1st if you qualify. Private insurance should get you down to that $25 range pretty quickly, though we all know how insurance approvals can go.
How it fits into the bigger picture
This gives us another real option in the tirzepatide and semaglutide world, which is honestly what we need. More competition usually means better prices and more access for everyone.
The oral format is probably the biggest selling point here. Plenty of people want the benefits of GLP-1 medications but just can't deal with weekly injections. Having two solid pill options now (Foundayo and oral Wegovy) opens doors for a lot more people.
Bottom Line
Foundayo isn't going to revolutionize weight loss, but it's a solid new option with reasonable pricing and good availability. If you've been waiting for a pill instead of an injection, this might be worth discussing with your doctor. Just don't expect it to work miracles - like all GLP-1 medications, it's a tool that works best alongside lifestyle changes.
